Work for Liminal BioSciences Inc.?

Claim Your Profile

Liminal BioSciences Inc. Logo Image

Liminal BioSciences Inc.

Liminal BioSciences Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report

Liminal BioSciences Inc.

Liminal BioSciences Inc. has reached its limit for free report views.

About Liminal BioSciences Inc.

201-500 Employees
Based in Laval, Quebec

Liminal Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis. The company is advancing promising research in small molecules for a range of diseases related to fibrosis including respiratory, liver and renal diseases. Through a separate business unit called Prometic, the company also focuses on the use of bioseparation technologies to isolate and purify biopharmaceuticals derived from human plasma.

Ticker:
LMNL
Exchange:
TSX (See More TSX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol